Home > Healthcare > Pharmaceuticals > Finished Drug Form > Blood Platelets Market
Blood Platelets Market size was valued at USD 5.6 billion in 2023 and is expected to exhibit growth at a CAGR of 4.2% from 2024 to 2032. The increasing prevalence of chronic and blood-related disorders coupled with growing demand for blood transfusions are significantly driving the market growth.
The growing incidence of chronic and blood-related disorders is a key factor driving the expansion of the market. Conditions such as cancer, cardiovascular diseases, and hemophilia frequently result in platelet deficiencies, fueling the need for platelet transfusions. Factors behind this trend include an aging population, lifestyle-related health issues, and increasing cancer rates. For instance, according to the World Health Organization, cardiovascular diseases are responsible for 17.9 million deaths annually, many involving platelet therapies. As the prevalence of these chronic and blood-related disorders continues to rise, the demand for blood platelets is expected to grow, further driving the market's expansion in the coming years.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Blood Platelets Market Size in 2023: | USD 5.6 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 4.2% |
2032 Value Projection: | USD 8.3 Billion |
Historical Data for: | 2021-2023 |
No. of Pages: | 100 |
Tables, Charts & Figures: | 161 |
Segments covered: | Platelet Type, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Moreover, the growing demand for blood transfusions diagnostics, particularly in trauma cases and surgical procedures, is further propelling the need for blood platelets. This increasing reliance on platelet transfusions is expected to significantly contribute to the sustained growth of the blood platelets market.
Blood platelets are small, disc-shaped cell fragments in the blood that play a crucial role in hemostasis, the process of stopping bleeding. They are produced in the bone marrow from larger cells called megakaryocytes and lack a nucleus, making them unique among blood components.